Aaron M. Wolfson

Clinical Assistant Professor of Medicine (Clinician Educator)

Program Director of the Advanced Heart Failure and Transplant Cardiology Training Program

Medical Director, Hypertrophic Cardiomyopathy Center

Image of Aaron M. Wolfson
Is this your profile? Click to edit

Overview

Dr. Aaron M. Wolfson is an Advanced Heart Failure and Transplant Cardiologist and Clinical Assistant Professor of Medicine at Keck School of Medicine of the University of Southern California.

Dr. Wolfson graduated from Boston University College of Engineering where he earned a BS (2006) and MS (2008) in Biomedical Engineering. He stayed at the Boston University School of Medicine and earned his MD in 2012 having earned Alpha Omega Alpha (AOA) honors as a 4th year medical student.

He completed his internal medicine residency at University of Chicago, general cardiology fellowship at Los Angeles County + University of Southern California, and advanced heart failure and transplant cardiology fellowship at Cedars-Sinai Medical Center. Prior to joining Keck Medicine of USC in December of 2020, Dr. Wolfson was an Assistant Professor of Medicine at the University of Arizona in Tucson, Arizona.

He is board certified in internal medicine, cardiovascular medicine, advanced heart failure and transplant cardiology and echocardiography. In addition to taking care of patients that have undergone heart transplantation or implantation of a durable mechanical circulatory support device, he has an active outpatient clinic and cares for patients with all types of heart failure, heart valve diseases, coronary artery disease, hypertension and hyperlipidemia. He also performs right heart catheterizations, right ventricular endomyocardial biopsies and implants CardioMEMS pressure sensors for remote hemodynamic monitoring of heart failure patients.

His research has focused on remote hemodynamic monitoring in heart failure, temporary mechanical circulatory support and heart transplantation. He has a growing number of high-impact research manuscripts that have been published in the Journal of Heart and Lung Transplantation and the American Journal of Transplantation.

Awards

  • National Biomedical Engineering Honor Society: Alpha Eta Mu Beta, 2005
  • National Engineering Honor Society: Tau Beta Pi, 2006
  • National Medical Honor Society: Alpha Omega Alpha, 2012
  • Morton Arnsdorf Cardiovascular Research Symposium, University of Chicago: Featured Presentation in Clinical and Translational Science, 2014
  • University of Chicago: University of Chicago Medicine Housestaff Teaching Award, 2015
  • California Chapter of the American College of Cardiology: Excellence in Cardiology Fellowship Award, 2018
  • Southern California Magazine, Los Angeles Times: Southern California Rising Stars, Super Doctors, 2023

Publications

  • Assessment of Aortic Characteristic Impedance and Arterial Compliance from Non-invasive Carotid Pressure Waveform in The Framingham Heart Study. Am J Cardiol. 2023 10 01; 204:195-199.. View in PubMed
  • New UNOS allocation system associated with no added benefit in waitlist outcomes and worse post-transplant survival in heart-kidney patients. J Heart Lung Transplant. 2023 11; 42(11):1529-1542.. View in PubMed
  • Effect of the UNOS policy change on rates of rejection, infection, and hospital readmission following heart transplantation. J Heart Lung Transplant. 2023 10; 42(10):1415-1424.. View in PubMed
  • UNOS policy change benefits high-priority patients without harming those at low priority. Am J Transplant. 2022 12; 22(12):2931-2941.. View in PubMed
  • Patient selection for heart transplant: balancing risk. Curr Opin Organ Transplant. 2022 02 01; 27(1):36-44.. View in PubMed
  • Dabigatran in cardiovascular disease management: A comprehensive review. World J Cardiol. 2021 Dec 26; 13(12):710-719.. View in PubMed
  • Effect of UNOS policy change and exception status request on outcomes in patients bridged to heart transplant with an intra-aortic balloon pump. Artif Organs. 2022 May; 46(5):838-849.. View in PubMed
  • Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation. Circ Heart Fail. 2020 02; 13(2):e006696.. View in PubMed
  • Amyloid and the Heart. Curr Cardiol Rep. 2019 12 03; 21(12):164.. View in PubMed
  • A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management. Cardiol Res Pract. 2019; 2019:7979830.. View in PubMed